When it comes to pharmacology, the big story these days is the development of the “glucagon-like peptide-1 (GLP-1) mimics,” the first truly effective medications to treat obesity. It’s a fascinating story to be sure, but get set for a bumpy ride.
News and analysis on drug development, clinical evidence, regulatory approvals, pharmacology, and the science behind treatments — from small molecules to biologics.
